Clinical Evaluation of Taurine in Congestive Heart Failure—A Double-Blind Comparative Study Using CoQ10 as a Control Drug

  • Junichi Azuma
  • Hiroshi Katsume
  • Tadashi Kagoshima
  • Keizo Furukawa
  • Nobuhisa Awata
  • Taro Ishiyama
  • Toru Yamagami
  • Hyoe Ishikawa
  • Heitaroh Iwata
  • Susumu Kishimoto
  • Yuichi Yamamura
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 93)

Abstract

Congestive heart failure is a clinical syndrome characterized by symptoms of dyspnea, fatigue, and edema that most commonly result from pathophysiological events following a severe insult to the left ventricle. In recent years, a new therapeutic approach based on the pathophysiology of congestive heart failure has been established. A single agent or combination therapy with cardiac glycosides and diuretics has proven to be effective in the treatment of congestive heart failure. However, in cases of refractory cardiac failure that resist these conventional drugs, vasodilators, sympathomimetics, and myocardial metabolism activators are used in combination therapy.

Keywords

Placebo Fatigue Depression Ischemia Dopamine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Katz AM 1986. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation 73:184–190.Google Scholar
  2. 2.
    Jacobsen JG, Smith LH Jr. 1968. Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 48:424–511.PubMedGoogle Scholar
  3. 3.
    Huxtable R, 1976. Metabolism and function of taurine in the heart. In Taurine, Huxtable R, Barbeau A, eds. New York: Raven Press, pp 99–120.Google Scholar
  4. 4.
    Huxtable R, Bressler R. 1974. Taurine concentrations in congestive heart failure. Science 184: 1187–1188.PubMedCrossRefGoogle Scholar
  5. 5.
    Takihara K, Azuma J, Awata N, Ohta H, Hamaguchi T, Sawamura A, Tanaka Y, Kishimoto S, Sperelakis N. 1986. Beneficial effect of taurine in rabbits with chronic congestive heart failure. Am Heart J 112:1278–1284.PubMedCrossRefGoogle Scholar
  6. 6.
    Sawamura A, Sperelakis N, Azuma J. 1986. Protective effect of taurine against decline of cardiac slow action potentials during hypoxia. Eur J Pharmacol 120:235–239.PubMedCrossRefGoogle Scholar
  7. 7.
    Ohta H, AzumaJ, Onishi S, Awata N, Takihara K, Kishimoto S. 1986. Protective effect of taurine against isoprenaline-induced myocardial damage. Basic Res Cardiol 81:473–481.PubMedCrossRefGoogle Scholar
  8. 8.
    Ohta H, Azuma J, Awata N, Hamaguchi T, Tanaka Y, Sawamura A, Kishimoto S, Sperelakis N. Mechanism of the protective action of taurine against isoprenaline-induced myocardial damage. 1988. Cardiovasc Res 22:407–413.PubMedCrossRefGoogle Scholar
  9. 9.
    Hamaguchi T, Azuma J, Awata N, Ohta H, Takihara H, Harada H, Kishimoto S, Sperelakis N. Reduction of doxorubicin-induced cardiotoxicity in mice by taurine. 1988. Res Commun Chem Path Pharmacol 59:21–30.Google Scholar
  10. 10.
    Azuma J, Hamaguchi T, Ohta H, Takihara K, Awata N, Sawamura A, Harada H, Tanaka Y, Kishimoto S. 1987. Calcium overload-induced myocardial damage caused by isoproterenol and by adriamycin: Possible role of taurine in its prevention. In The biology of taurine, Huxtable RJ, Franconi F, Giotti A, eds. New York: Plenum Press, pp 167–179.Google Scholar
  11. 11.
    Takihara K, Azuma J, Awata N, Ohta H, Sawamura A, Kishimoto S, Sperelakis N. Taurine’s possible proteccive role in age-dependent response to calcium paradox. 1985. Life Sci 37: 1705–1710.PubMedCrossRefGoogle Scholar
  12. 12.
    Harada H, Cusack B, Olson B, Stroo W, Azuma J, Hamaguchi T, Schaffer SW. Role for intracellular taurine pool in the Adriamycin-stressed myocardium. Biochem Pharmacol, in press.Google Scholar
  13. 13.
    Takihara K, Azuma J, Onishi S, Kishimoto S, Sperelakis N. Protection by taurine of calcium paradox-related damage in cardiac muscle: Its regulatory action on intracellular cation contents. 1988. Biochem Pharmacol 37:2651–2658.CrossRefGoogle Scholar
  14. 14.
    Dolara P, Ledda F, Mugelli A, Mantelli L, Zilletti L, Franconi F, Giotti A. 1978. Effect of taurine on calcium, inotropism, and electrical activity of the heart. In Taurine and neurological disorders, Barbeau A, Huxtable RJ eds. New York: Raven Press, pp 151–159.Google Scholar
  15. 15.
    Kramer JH, Chovan JP, Schaffer SW. 1981. Effect of taurine on calcium paradox and ischemic heart failure. Am J Physiol 240:H238-H246.PubMedGoogle Scholar
  16. 16.
    Azuma J, Hasegawa H, Sawamura A, Awata N, Harada H, Ogura K, Kishimoto S. 1982. Taurine for treatment of congestive heart failure. Int J Cardiol 2:303–304.PubMedCrossRefGoogle Scholar
  17. 17.
    Azuma J, Hasegawa H, Sawamura A, Awata N, Ogura K, Harada, H, Yamaura Y, Kishimoto S. 1983. Therapy of congestive heart failure with orally administered taurine. Clin Ther 5: 398–408.PubMedGoogle Scholar
  18. 18.
    Azuma J, Hasegawa H, Awata N, Sawamura A, Harada H, Ogura K, Yamauchi K, Kishimoto S. 1983. Taurine for treatment of congestive heart failure in humans. In Sulfur amino acids: Biochemical and clinical aspects, Kuriyama K, Huxtable RJ; Iwata H eds. New York: Alan R. Liss, pp 61–72.Google Scholar
  19. 19.
    Azuma J, Sawamura A, Awata N, Hasegawa H, Ogura K, Harada H, Ohta H, Yamauchi K, Kishimoto S, Yamagami T, Ueda E, Ishiyama T. 1983. Double-blind randomized crossover trial of taurine in congestive heart failure. Current Ther Res 34:543–553.Google Scholar
  20. 20.
    Azuma J, Sawamura A, Awata N, Ohta H, Hamaguchi T, Harada H, Takihara K, Hasegawa, H, Yamagami T, Ishiyama T, Iwata H, Kishimoto S. 1985. Therapeutic effect of taurine in congestive heart failure: A double-blind crossover trial. Clin Cardiol 8:276–282.PubMedCrossRefGoogle Scholar
  21. 21.
    Criteria Committee of the New York Heart Association. 1973. In Nomenclature and criteria for diagnosis of disease of the heart and blood vessels, 7th ed. Boston: Little, Brown.Google Scholar
  22. 22.
    Colucci, WS., Wright RF, Braunwald E. 1986. New positive inotropic agents in the treatment of congestive heart failure: Mechanisms of action and recent clinical developments. N Engl J Med 314:290–299.PubMedCrossRefGoogle Scholar
  23. 23.
    Colucci WS, Wright RF, Braunwald E. 1986. New positive inotropic agents in the treatment of congestive heart failure: Mechanisms of action and recent clinical developments. N. Engl J Med 314:349–358.PubMedCrossRefGoogle Scholar
  24. 24.
    Braunmald E, Colucci W. 1984. Evaluating the efficacy of new inotropic agents. J Am Coll Cardiol 3:1570–1574.CrossRefGoogle Scholar
  25. 25.
    Franconi F, Stendardi I, Matucci R, Failli P, Bennardini F, Antonini G, Giotti A. 1984. Inotropic effect of taurine in guinea-pig ventricular strips. Eur J Pharmacol 102:511–514.PubMedCrossRefGoogle Scholar
  26. 26.
    Sawamura A, Azuma J, Harada H, Hasegawa H, Ogura K, Sperelakis N, Kishimoto S 1983. Protection by oral pre-treatment with taurine against the negative inotropic effects of low-calcium medium on isolated perfused chick heart. Cardiovasc Res 17:620–626.PubMedCrossRefGoogle Scholar
  27. 27.
    Franconi F, Giotti A, Manzini S, Martini F, Stendardi I, Zilletti L. 1982. Observations on the action of taurine at arterial and cardiac levels. In Taurine in nutrition and neurology, Huxtable R, Pasantes-Morales H, eds. New York: Plenum Press, pp. 181–190.Google Scholar
  28. 28.
    Franconi F, Martini F, Stendardi I, Matucci R, Zilletti L, Giotti A. 1982. Effect of taurine on calcium levels and contractility in guinea-pig ventricular strips. Biochem Pharmacol 31: 3181–3186.PubMedCrossRefGoogle Scholar
  29. 29.
    Awata N, Azuma J, Hamaguhi T, Tanaka Y, Ohta H, Takihara K, Harada H, Sawamura A, Kishimoto S. Acute haemodynamic effect of taurine on the hearts in vivo with normal and depressed myocardial function. 1987. Cardiovasc Res 21:241–247.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Acacdemic Publishers, Boston/Dordrecht/London 1989

Authors and Affiliations

  • Junichi Azuma
  • Hiroshi Katsume
  • Tadashi Kagoshima
  • Keizo Furukawa
  • Nobuhisa Awata
  • Taro Ishiyama
  • Toru Yamagami
  • Hyoe Ishikawa
  • Heitaroh Iwata
  • Susumu Kishimoto
  • Yuichi Yamamura

There are no affiliations available

Personalised recommendations